DIFFERENTIAL-EFFECTS OF CYCLOSPORINE ON HEPATIC AND RENAL HEME, CYTOCHROME-P-450 AND DRUG-METABOLISM - POSSIBLE ROLE IN NEPHROTOXICITY OF THE DRUG

被引：44

作者：

MAYER, RD ^{[1
]}

BERMAN, S ^{[1
]}

COCKETT, ATK ^{[1
]}

MAINES, MD ^{[1
]}

机构：

[1] UNIV ROCHESTER,SCH MED,DEPT BIOPHYS,ROCHESTER,NY 14642

来源：

BIOCHEMICAL PHARMACOLOGY | 1989年 / 38卷 / 06期

关键词：

D O I：

10.1016/0006-2952(89)90291-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1001 / 1007

页数：7

共 43 条

[1]

AUGUSTINE JA, 1986, DRUG METAB DISPOS, V14, P73

[2] CYTOCHROME P-450-DEPENDENT OXYGENATION OF ARACHIDONIC-ACID TO HYDROXYICOSATETRAENOIC ACIDS [J].

CAPDEVILA, J ;

MARNETT, LJ ;

CHACOS, N ;

PROUGH, RA ;

ESTABROOK, RW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (03) :767-770

[3] EVIDENCE THAT RENAL PROSTAGLANDIN AND THROMBOXANE PRODUCTION IS STIMULATED IN CHRONIC CYCLOSPORINE NEPHROTOXICITY [J].

COFFMAN, TM ;

CARR, DR ;

YARGER, WE ;

KLOTMAN, PE .

TRANSPLANTATION, 1987, 43 (02) :282-285

[4] AMELIORATION OF CYCLOSPORIN-INDUCED NEPHROTOXICITY IN RATS BY INDUCTION OF HEPATIC DRUG-METABOLISM [J].

CUNNINGHAM, C ;

BURKE, MD ;

WHEATLEY, DN ;

THOMSON, AW ;

SIMPSON, JG ;

WHITING, PH .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (04) :573-578

[5] MODIFIED METHOD FOR ASSAY OF BENZO[A]PYRENE HYDROXYLASE [J].

DEHNEN, W ;

TOMINGAS, R ;

ROOS, J .

ANALYTICAL BIOCHEMISTRY, 1973, 53 (02) :373-383

[6] THE VITAMIN-D STORY - A COLLABORATIVE EFFORT OF BASIC SCIENCE AND CLINICAL MEDICINE [J].

DELUCA, HF .

FASEB JOURNAL, 1988, 2 (03) :224-236

[7] CYTOCHROME P450K OF RAT-KIDNEY CORTEX MICROSOMES - ITS INVOLVEMENT IN FATTY-ACID OMEGA-HYDROXYLATION AND(OMEGA-1)-HYDROXYLAATION [J].

ELLIN, A ;

SCHENKMAN, JB ;

JAKOBSSON, SV ;

ORRENIUS, S .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1972, 150 (01) :64-+

[8] MODIFICATION OF EXPERIMENTAL NEPHROTOXICITY WITH FISH OIL AS THE VEHICLE FOR CYCLOSPORINE [J].

ELZINGA, L ;

KELLEY, VE ;

HOUGHTON, DC ;

BENNETT, WM .

TRANSPLANTATION, 1987, 43 (02) :271-274

[9]

Estabrook R W, 1978, Methods Enzymol, V52, P212

[10]

GALINSKY RE, 1987, DRUG METAB DISPOS, V15, P731

← 1 2 3 4 5 →